EFPIA - European Federation of Pharmaceutical Industries and Associations

#Imagine if Europe found the treatment to slow Alzheimer’s progression, produced the first vaccine for brain cancer or medicines that could transform the lives of patients with chronic disease. Now we've imagined. Let's take action: https://shorturl.at/cCGVZ #WeWontRest

The EFPIA team wishes you happy, healthy holidays! May they be filled with love, joy, and all the happiness you can imagine.

Introducing #TheHive – a cutting-edge scientific research ecosystem based at our R&D centre in Barcelona. This initiative is designed to foster collaboration between researchers from biotech companies, start-ups, academia, key opinion leaders, and Almirall's own scientists. The Hive is not just a space; it's a vision for the future of innovation. By bringing together diverse expertise, we aim to accelerate research and transform ideas into impactful solutions for patients. We are proud to continue advancing innovation and collaboration through this pioneering initiative! #TheHive #OpenInnovation #WeAreAlmirall Marc A. Soriano Jorge Gil-Martinez Javier Terriente

Investment in #medicines #research and #development in Europe has grown 4.4% every year between 2010 and 2022. China has grown nearly 5 times faster. How can Europe #RebootLifeSciences and close the gap? https://lnkd.in/dW2MY7is   #WeWontRest

Gene therapies offer patients living with #rare #diseases like Duchenne Muscular Dystrophy the hope of relief from pain - and maybe even a cure. #Imagine how many lives could be changed. Discover more in our #pipeline #review: https://lnkd.in/dqv6B-6p #WeWontRest

EFPIA is looking for a Legal Affairs Manager to focus on Corporate Sustainability & Policy, environmental regulations, and policy development. Check the job description to find out more: https://lnkd.in/daTgjrv

I was delighted to join a panel in Brussels at the EFPIA - European Federation of Pharmaceutical Industries and Associations ‘Imagine a healthier, more competitive Europe’ event to discuss how industry, policymakers and patient advocates can work together to ensure faster, more equitable access to medicines. It was a privilege to share the stage with fellow panellist, Minister for Health of the Republic of Latvia Hosams Abu Meri. We all agree on the diagnostic: access in Europe needs to be fixed. How? A few reflections: 1. Access can only happen if a favorable ecosystem for medicines is in place. Political will and multistakeholder dialogue are key to move the needle in the right direction. 2. The revision of the #EU General Pharma Legislation, along with the promised European Life Sciences Strategy, are opportunities to restore European competitiveness. 3. Europe should work towards ensuring continued investments in innovation, a workable EU HTA system, and an agile and future-proof regulatory framework When we work together, we can turn ambition into action to build a healthier, more competitive, and secure Europe. #WeWontRest #BMS_Employee

What happens if the antibiotics modern medicine relies on, no longer work? The threat of #AntimicrobialResistance (#AMR) is becoming better recognised and understood. But something less talked about is the potential impact of AMR on vulnerable people tackling another feared disease – cancer. One of the common effects of cancer treatment is a compromised immune system. As many as 1 in 5 cancer patients undergoing treatment are hospitalized due to bacterial infection.* It is vital we keep the power of anti-infective medicines alive for today’s cancer community and future patients. Something this video brings to life so powerfully. * Bratti VF et al. Protocol: Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes. BMJ Open. 2023;13(1):e068122. Published 2023

Self-regulation plays a vital role in governing how pharmaceutical companies promote medicines, interact with health professionals and collaborate with the patient community. It is undoubtedly a privilege and one which requires accountability and commitment to high standards from the organisations and companies involved as well as significant investment. Through our proactive approach, we can continually improve and enforce standards and embed them throughout the sector, to deliver on our mission to help patients. Read more in this blog by Julie BONHOMME and Alex Fell: https://lnkd.in/dbnGQR96 #WeWontRest

Viral infections can cause several #cancers, and are also believed to play a role in the onset of other conditions like multiple sclerosis. #Imagine if #vaccines could prevent these infections. #Imagine how different the future might look. Discover more in our #pipeline review: https://lnkd.in/dqv6B-6p #WeWontRest